Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 889 of 5804
-
Which diabetes drug is better for heart failure? new study compares tirzepatide and semaglutide
Disease control CompletedInvestigators are building an empirical evidence base for real-world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Mindfulness and walking may ease pain and protect memory in older black adults
Symptom relief Recruiting nowThe investigators aim to conduct a randomized controlled trial to compare two symptom-management programs for Black older adults with early cognitive decline (self-reported confirmed by testing) and chronic pain. The programs are Mindfulness-Based Cognitive Therapy with Walking (…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
New oral drug HRS-5965 shows promise for tough PNH anemia cases
Disease control CompletedThis trial is a multi-center, single-arm, open-label phase III clinical trial. A total of approximately 35 patients with paroxysmal nocturnal hemoglobinuria who remained anemic despite stable use of C5 complement inhibitor (eculizumab/Kevacumab) for the first 6 months before rand…
Phase: PHASE3 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Revolutionary scan could spot hidden heart attack clots
Diagnosis Recruiting nowWe now have very sensitive blood tests that can pick up damage to the heart and find patients who have had a heart attack. However, whilst this is welcome, it does not identify what causes the heart attack and can sometimes pick up other conditions that cause a strain on the hear…
Sponsor: University of Edinburgh • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Drug-Releasing ear implant could boost hearing for millions
Symptom relief OngoingThis clinical study will test a new type of cochlear implant known as CI632D. This experimental cochlear implant has been designed to slowly release a drug called dexamethasone. Dexamethasone works to ease inflammation and reduce tissue injury, which is common after any type of s…
Phase: NA • Sponsor: Cochlear • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Personalizing PTSD care: motivation and choice may boost recovery
Disease control Recruiting nowThe goal of this clinical study is to improve the outcome of outpatient PTSD treatment at two clinics treating majority ethnic Danes and refugees with PTSD respectively. The study will consist of two similar randomized controlled trials. The main questions the study aims to answ…
Phase: NA • Sponsor: Herlev and Gentofte Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New Clot-Busting drug could change heart attack care
Disease control Recruiting nowThe goal of this clinical trial is to compare the efficacy and safety of intracoronary rhTNK-tPA or Tirofiban in patients with ST-segment elevation myocardial infarction and high thrombus burden. The main questions it aims to answer are: * Is the efficacy of intracoronary rhTNK-…
Phase: PHASE4 • Sponsor: Henan Institute of Cardiovascular Epidemiology • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Tiny implant aims to restore hand grip after spinal cord injury
Disease control Recruiting nowThe purpose of this study is to evaluate a new method of restoring hand function to people with spinal cord injury. Current methods to restore hand function include tendon transfers and nerve transfers. This study will evaluate the grasp strength that can be achieved with a small…
Phase: NA • Sponsor: MetroHealth Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Injectable HIV treatment tested over five years in thousands of patients
Disease control OngoingThe RELATIVITY study is a nationwide, multicenter, ambispective observational cohort evaluating the long-term effectiveness, safety, persistence, and tolerability of long-acting injectable cabotegravir plus rilpivirine (CAB+RPV LA) in people living with HIV in Spain. The study i…
Sponsor: FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a cheaper keytruda copy work just as well for lung cancer?
Disease control Recruiting nowThis is a randomized, multicenter, multinational, double-blind, integrated pharmacokinetics (PK) and efficacy similarity study to compare the PK, efficacy, safety, and immunogenicity of MB12 versus Keytruda® in combination with pemetrexed-platinum chemotherapy as first-line treat…
Phase: PHASE3 • Sponsor: mAbxience Research S.L. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New cancer drug FH-006 enters human trials for solid tumors
Disease control Recruiting nowEvaluate the safety, tolerability, pharmacokinetics, and immunogenicity of FH-006 in subjects with advanced malignant solid tumors, and determine the maximum tolerated dose (MTD) or maximum administered dose (MAD), recommended dose for phase II clinical trials (RP2D), and prelimi…
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Head-to-Head: which pill tames hidradenitis suppurativa best?
Disease control CompletedThis randomized controlled trial compares the efficacy of oral apremilast and oral acitretin in the treatment of moderate-to-severe hidradenitis suppurativa. Seventy eligible adults were randomly assigned to receive either apremilast (30 mg twice daily) or acitretin (25 mg twice …
Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New depression pill could lift the fog without lifelong dependence
Symptom relief Recruiting nowX-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
AI heart scan trial aims to sharpen diagnosis of clogged arteries
Diagnosis OngoingPARAMOUNT is a prospective randomized open-label trial testing the hypothesis that a personalized management strategy in symptomatic patients with suspicion of coronary artery disease (CAD), using a CT-based coronary atherosclerotic plaque assessment by AI-enabled quantitative so…
Phase: NA • Sponsor: Cleerly, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
Brain scan breakthrough: new tracer could catch Parkinson's early
Diagnosis CompletedThe main objective of this study is to establish a standardized method for \[18F\] - FD17 PET imaging in α-synucleinopathy patients, and to analyze its physiological distribution in healthy individuals as well as its pathological distribution in α-synucleinopathy patients, includ…
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
Could a smaller surgery be just as safe for early colon cancer?
Disease control Recruiting nowThe aim of this study is to reduce the need for colectomy and its' associated morbidity and mortality in patients with pT1-2 colon carcinoma after endoscopic resection and an estimated lymph node metastasis (LNM) risk of \>15%, or with macroscopically suspected T1 tumors, by perf…
Phase: NA • Sponsor: Meander Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug cocktail aims to tame metastatic prostate cancer
Disease control Recruiting nowThe purpose of this study was to observe and evaluate the tolerability, safety, and pharmacokinetics of HRS-1167 combined with abiraterone acetate tablets (II) and prednisone in patients with metastatic prostate cancer, determine the RP2D, and evaluate the effectiveness.
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 12:48 UTC
-
New trial tests faster radiation for prostate cancer relapse
Disease control Recruiting nowThis is a a randomized phase II/III trial comparing salvage SBRT with standard of care (SOC) regimens for patients with a persistent detectable PSA or biochemical progression during follow-up after radical prostatectomy.
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug combo shows promise in shrinking esophageal tumors before surgery
Disease control Recruiting nowThis study is a prospective, single-arm, phase II exploratory clinical trial. The primary endpoint of this study is to evaluate the pathological complete response (pCR) rate after surgery and to assess the safety of neoadjuvant therapy with adebrelimab combined with platinum-base…
Phase: NA • Sponsor: The Second Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Lab-Grown tumor avatars could personalize breast cancer treatment
Disease control Recruiting nowA biopsy of a tumor lesion (breast or other localisation) will be performed for processing to establish avatars (patient-derived organoids -PDO). A personalized tumorogram for each patient will be provided, based on the results of the drug screening (= tumor predicted as sensitiv…
Phase: NA • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC